Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

Sector: Pharmaceutical Preparations Region: MD, United States

: | Nasdaq: NWBO | Nasdaq: NWBOW

Similar to: AstraZeneca Plc, Cephalon, Inc., United-Guardian, Inc.

Northwest Biotherapeutics, Inc. is engaged in the development and discovery of innovative immunotherapies for cancer. Its products includes Dendritic Cell Immunotherapy, Therapeutic Monoclonal Antibodies, and Imaging Metastatic Prostate Cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

News & Analysis

You may also be interested in: